Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Create alerts with multiple filters including highs/low, comparative values, and turning points. FREE 30 Day Trial

Stocks | Futures | Watchlist | More
or

Siga Technologies Inc (SIGA)

Siga Technologies Inc (SIGA)

[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Profile for [[ item.sessionDateDisplayLong ]]

Company Info

Siga Technologies Inc 31 EAST 62ND STREET NEW YORK NY 10065 USA

P: 212-672-9100

Description:

SIGA Technologies Inc. is applying viral and bacterial genomics and sophisticated computational modeling in the design and development of novel products for the prevention and treatment of serious infectious diseases, with an emphasis on products for biological warfare defense. SIGA believes that it is a leader in the development of pharmaceutical agents and vaccines to fight potential biowarfare pathogens. With broad technology platforms in both vaccines and antibiotics, SIGA's product development programs emphasize the increasingly serious problem of drug resistant bacteria. In addition to smallpox, SIGA has antiviral programs targeting other Category A pathogens, including arenaviruses, dengue virus, and the filoviruses.

Key Statistics

Overview:

Market Capitalization, $K 1,808,805
Enterprise Value, $K 1,705,665
Shares Outstanding, K 73,024
Annual Sales, $ 133,670 K
Annual Net Income, $ 69,450 K
Last Quarter Sales, $ 16,670 K
Last Quarter Net Income, $ 2,040 K
60-Month Beta 0.63
% of Insider Shareholders 2.12%
% of Institutional Shareholders 34.52%
Float, K 71,476
% Float 97.88%
Short Volume Ratio 0.53

Growth:

1-Year Return 263.32%
3-Year Return 402.43%
5-Year Return 714.80%
5-Year Revenue Growth 791.73%
5-Year Earnings Growth 31.88%
5-Year Dividend Growth 0.00%

Per-Share Information:

Most Recent Earnings 0.03 on 08/04/22
Next Earnings Date N/A
Earnings Per Share ttm 0.96
EPS Growth vs. Prev Qtr 400.00%
EPS Growth vs. Prev Year 71.97%
Annual Dividend Rate, $ 0.00
Annual Dividend Yield 0.00%
Dividend Payout Ratio 45.79%

SIGA Ratios

Ratio
Price/Earnings ttm 25.33
Price/Earnings forward 36.85
Price/Earnings to Growth N/A
Return-on-Equity % 48.79%
Return-on-Assets % 41.32%
Profit Margin % 51.96
Net Margin % 8.17
Debt/Equity 0.00
Price/Sales 13.29
Price/Cash Flow 25.76
Price/Book 12.71
Book Value/Share 1.91
Interest Coverage 0.00
Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar